default author photo

Matthew A. Spinelli

University of California, San Francisco (UCSF) - Division of HIV, Infectious Diseases and Global Medicine

995 Potrero Ave

Ward 84

San Francisco, CA 94110

United States

SCHOLARLY PAPERS

5

DOWNLOADS

328

TOTAL CITATIONS

4

Scholarly Papers (5)

1.

Post-Mrna Vaccination SARS-CoV-2 IGG Concentrations and Surrogate Virus Neutralization Response Compared by HIV Status and Type of Vaccine: A Matched Case-Control Observational Study

Number of pages: 13 Posted: 25 Aug 2021
University of California, San Francisco (UCSF) - Division of HIV, Infectious Diseases and Global Medicine, University of California, San Francisco (UCSF) - Division of HIV, Infectious Diseases and Global Medicine, University of California, San Francisco (UCSF) - Department of Laboratory Medicine, University of California, San Francisco (UCSF) - Department of Laboratory Medicine, University of California, San Francisco (UCSF) - Department of Epidemiology and Biostatistics, University of California, San Francisco (UCSF) - Division of HIV, Infectious Diseases and Global Medicine, University of California, San Francisco (UCSF) - Department of Medicine and University of California, San Francisco (UCSF) - Division of HIV, Infectious Diseases and Global Medicine
Downloads 95 (715,072)
Citation 3

Abstract:

Loading...

2.

Impact of Multi-Component Support Strategies on HIV Virologic Suppression Rates During Covid-19: An Interrupted Time Series Analysis

Number of pages: 25 Posted: 18 Nov 2021
University of California, San Francisco (UCSF) - Division of HIV, Infectious Diseases and Global Medicine, University of California, San Francisco (UCSF) - Division of HIV, Infectious Diseases and Global Medicine, University of California, San Francisco (UCSF) - Department of Epidemiology and Biostatistics, San Francisco Department of Health, University of California, San Francisco (UCSF) - Division of HIV, Infectious Diseases and Global Medicine, University of California, San Francisco (UCSF) - Division of HIV, Infectious Diseases and Global Medicine, University of California, San Francisco (UCSF) - Division of HIV, Infectious Diseases and Global Medicine, University of California, San Francisco (UCSF) - Department of Psychiatry, University of California, San Francisco (UCSF) - Division of HIV, Infectious Diseases and Global Medicine, University of California, San Francisco (UCSF) - Department of Epidemiology and Biostatistics, University of California, San Francisco (UCSF) - Division of Prevention Science, University of California, San Francisco (UCSF) - Division of HIV, Infectious Diseases and Global Medicine, University of California, San Francisco (UCSF) - Division of HIV, Infectious Diseases and Global Medicine and University of California, San Francisco (UCSF) - Division of HIV, Infectious Diseases and Global Medicine
Downloads 76 (830,555)

Abstract:

Loading...

HIV, Virologic Suppression, COVID-19, Interrupted time series, housing intervention

3.

The Impact of Adherence Counselling Incorporating a Point of Care Urine Tenofovir Assay on Virologic Suppression Among Individuals Failing Tenofovir-Lamivudine-Dolutegravira Pre - Post Intervention Study

Number of pages: 24 Posted: 30 Jul 2024
Government of Namibia - Ministry of Health and Social Services, University of California, San Francisco (UCSF) - Division of HIV, Infectious Diseases and Global Medicine, University of California, San Francisco (UCSF) - Global Health Group, Namibia Institute of Pathology Limited, Government of Namibia - Ministry of Health and Social Services, Government of Namibia - Ministry of Health and Social Services, Namibia Institute of Pathology Limited, Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC), University of California, San Francisco (UCSF), Abbott Laboratories, University of California, San Francisco (UCSF), University of California, San Francisco (UCSF), Government of the United States of America - Centers for Disease Control and Prevention (CDC), Harvard University - Harvard Medical School, Harvard University - Massachusetts General Hospital, University of California, San Francisco (UCSF) - Division of HIV, Infectious Diseases and Global Medicine and Government of the United States of America - Centers for Disease Control and Prevention (CDC)
Downloads 63 (933,592)

Abstract:

Loading...

tenofovir-lamivudine-dolutegravir (TLD), people with HIV (PWH), virologic suppression, VS, urine tenofovir assay, point-of-care assay, enhanced adherence counseling, Namibia

4.

Development and Validation of an Immunoassay for Tenofovir in Urine as a Real-Time Metric of Antiretroviral Adherence

Number of pages: 69 Posted: 21 Sep 2018
University of California, San Francisco (UCSF) - Division of HIV, Infectious Diseases and Global Medicine, University of California, San Francisco (UCSF) - Department of Epidemiology and Biostatistics, Immunalysis, University of California, San Francisco (UCSF) - Division of HIV, Infectious Diseases and Global Medicine, University of California, San Francisco (UCSF), University of Washington - Department of Global Health, University of Washington - Department of Global Health, University of Washington - Department of Global Health, Jomo Kenyatta University of Agriculture and Technology, University of California, San Francisco (UCSF) - Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco (UCSF) - Department of Bioengineering and Therapeutic Sciences, Immunalysis and Immunalysis
Downloads 48 (1,086,013)
Citation 1

Abstract:

Loading...

Antiretroviral adherence, tenofovir, immunoassay, antibody, PrEP, antiretroviral treatment, real-time, point-of-care, urine, test characteristics

5.

Seroprevalence, Neutralizing Antibody Titers Following Infection, and COVID-19 Disease Severity Differ Among People With and Without HIV

Number of pages: 24 Posted: 11 Mar 2021
University of California, San Francisco (UCSF) - Division of HIV, Infectious Diseases and Global Medicine, University of California, San Francisco (UCSF) - Department of Laboratory Medicine, University of California, San Francisco (UCSF) - Department of Laboratory Medicine, University of California, San Francisco (UCSF) - Department of Epidemiology and Biostatistics, University of California, San Francisco (UCSF) - Division of HIV, Infectious Diseases and Global Medicine, University of California, San Francisco (UCSF) - Division of HIV, Infectious Diseases and Global Medicine, University of California, San Francisco (UCSF) - Division of HIV, Infectious Diseases and Global Medicine and University of California, San Francisco (UCSF) - Division of HIV, Infectious Diseases and Global Medicine
Downloads 46 (1,109,210)

Abstract:

Loading...